Clinical Trials Logo

Clinical Trial Summary

This is a study of liposomal bupivacaine for pain control in patients with blunt chest wall trauma.


Clinical Trial Description

The purpose of this study is to evaluate the efficacy of liposomal bupivacaine to provide analgesia via paravertebral intercostal nerve block following significant blunt chest trauma, minimizing adverse outcomes, length of stay and overall narcotic use. The primary outcome of the study is to compare requirements between the bupivacaine group and a standard-of-care group. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT02749968
Study type Interventional
Source University of Cincinnati
Contact
Status Completed
Phase Phase 2
Start date March 9, 2018
Completion date January 1, 2021

See also
  Status Clinical Trial Phase
Enrolling by invitation NCT06069154 - Ultrasound-Guided Percutaneous Cryoneurolysis to Treat Pain Following Thoracic Trauma N/A
Completed NCT00774618 - Evaluation of Surgical Treatment on Pain and Disability for Chronic, Non-healing Rib Fracture Phase 4
Completed NCT00556543 - Clinical Study of the U-Plate Fracture Repair System to Treat Rib Fractures N/A
Completed NCT02487264 - Analysis of the Status, Treatment and Outcomes of Rib Fractures
Completed NCT02028611 - Comparison of Gray-scale Inverted Rib Series With Conventional Ones in Rib Fracture Detection by Emergency Physicians and Medical Students N/A
Terminated NCT03846024 - Orthosis of Acute Traumatic Rib Fractures Via RibFx Belt for Pain Alleviation and Improved Pulmonary Function N/A
Active, not recruiting NCT01367951 - Treatment of Acute, Unstable Chest Wall Injuries N/A
Terminated NCT01327287 - Early Aggressive Pain Management is Associated With Improved Outcomes in Blunt Thoracic Trauma N/A
Recruiting NCT02595593 - Rib Fixation for Clinically Severe Rib Fractures From Trauma N/A